retatrutide vs tirzepatide vs semaglutide terzepatide vs. Ozempic: The Triple Agonist That May Change Everything. hits one receptor Retatrutide (GLP-3) Results: What Trials

Increased striatal adenosine A2A receptor levels is an early event in Parkinsons disease-related pathology and it is potentially regulated by miR-34b

Rompe JD, Segal NA, Cacchio A, Furia JP, Morral A, Maffulli N

In fact, it's like a barge or wheelbarrow

Targeting these amino acid-driven metabolic circuits may offer novel therapeutic opportunities in fibrotic diseases such as IPF, where metabolic vulnerabilities can be exploited to disrupt fibroblast activation and excessive ECM remodeling

A smaller liraglutide trial demonstrated no reduction in A burden or cognitive change though it preserved brain glucose metabolism